News and Events
Learn more about current happenings at Ergomed.
In this interview, Ergomed’s CFO Richard Barfield runs through:
Ergomed is a global full-service CRO business with a core focus on the US and EU. It provides Phase I–III clinical services in addition to post-marketing pharmacovigilance (Phase IV) services through its PrimeVigilance division. The company is predominantly focused on oncology, orphan drugs, rare diseases and pharmacovigilance.